04.12.2024 13:38 | ONC | Holding(s) in Company | RNS |
13.11.2024 17:06 | ONC | Holding(s) in Company | RNS |
13.11.2024 11:41 | ONC | Holding(s) in Company | RNS |
12.11.2024 17:17 | ONC | Holding(s) in Company | RNS |
12.11.2024 16:49 | ONC | Holding(s) in Company | RNS |
11.11.2024 11:15 | ONC | Director/PDMR Shareholding | RNS |
08.11.2024 14:37 | ONC | Results of General Meeting and Total Voting Rights | RNS |
01.11.2024 13:31 | ONC, AYM | UK shareholder meetings calendar - next 7 days | Alliance |
31.10.2024 17:07 | ONC | Result of Retail Offer | RNS |
31.10.2024 14:09 | ONC | Oncimmune Holdings shares tick up as notes new contracts | Alliance |
31.10.2024 07:00 | ONC | Trading Update | RNS |
23.10.2024 16:12 | ONC | Posting of Circular and Notice of General Meeting | RNS |
21.10.2024 12:30 | ONC | UPDATE: Oncimmune raises GBP2.2 million in equity as planned | Alliance |
18.10.2024 15:05 | ONC | Result of Placing & Issue of Equity | RNS |
18.10.2024 12:44 | ONC | IN BRIEF: Oncimmune converts debt and offers shares in growth push | Alliance |
18.10.2024 08:00 | ONC | Retail Offer | RNS |
18.10.2024 07:47 | ONC | Fundraising and Amendments to Facility | RNS |
09.09.2024 11:42 | ONC | Oncimmune expects "substantial" revenue growth following contract wins | Alliance |
09.09.2024 07:00 | ONC | Trading Update | RNS |
02.09.2024 17:35 | ONC | Oncimmune Holdings agrees new contract valued at USD700,000 | Alliance |
02.09.2024 07:00 | ONC | Contract Win | RNS |
09.08.2024 17:15 | EARN, TERN, KINO | TRADING UPDATES: Tan Delta signs contract; Earnz loss widens | Alliance |
09.08.2024 11:21 | HUM, ONC, KZG | AIM WINNERS & LOSERS: Hummingbird falls on mining challenges | Alliance |
09.08.2024 07:00 | ONC | US$1.5m Contract Win with Top 10 Pharma Company | RNS |
24.06.2024 11:18 | ONC | Holding(s) in Company | RNS |
17.06.2024 14:30 | ONC | Holding(s) in Company | RNS |
29.05.2024 17:45 | ONC | Holding(s) in Company | RNS |
21.05.2024 16:27 | WRKS, DXRX, TPT | EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss | Alliance |
21.05.2024 07:00 | ONC | Interim Results | RNS |
17.05.2024 10:11 | ONC | Investor Presentation via Investor Meet Company | RNS |
09.05.2024 15:08 | ONC | Holding(s) in Company | RNS |
26.04.2024 07:00 | ONC | Appointment of Nominated Adviser and Joint Broker | RNS |
25.04.2024 10:44 | ONC | Holding(s) in Company | RNS |
02.04.2024 11:34 | ONC | Result of General Meeting | RNS |
02.04.2024 08:00 | ONC | Total Voting Rights | RNS |
26.03.2024 11:18 | ONC | Holding(s) in Company | RNS |
13.03.2024 17:32 | ONC | Block Listing Return | RNS |
06.03.2024 15:02 | ONC | Posting of Notice of General Meeting | RNS |
01.03.2024 13:00 | ONC | Investor Presentation via Investor Meet Company | RNS |
29.02.2024 17:00 | MACF, RSE, ONC | EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout | Alliance |
29.02.2024 11:19 | ONC | Holding(s) in Company | RNS |
29.02.2024 07:00 | ONC | Final Results | RNS |
26.02.2024 11:30 | ONC | Result of AGM | RNS |
19.02.2024 12:54 | ONC | UK shareholder meetings calendar - next 7 days | Alliance |
11.12.2023 15:12 | ONC | Director/PDMR Shareholding | RNS |
08.12.2023 14:31 | ONC | Grant of Options and PDMR Dealing | RNS |
30.11.2023 14:25 | ARK, ONC, SBTX | TRADING UPDATES: SkinBio launches food supplement on Amazon | Alliance |
30.11.2023 07:00 | ONC | Progress against Strategy | RNS |
10.11.2023 10:14 | ONC | Holding(s) in Company | RNS |
07.11.2023 16:11 | ONC | Grant of Options and PDMR Dealing | RNS |
19.10.2023 07:00 | ONC | Investor Presentation via Investor Meet Company | RNS |
12.10.2023 14:21 | ONC | IN BRIEF: Oncimmune shares jump following new strategy update | Alliance |
12.10.2023 07:00 | ONC | Update on Strategy & Changes to the Board | RNS |
01.08.2023 07:00 | ONC | Board Changes | RNS |
14.07.2023 14:00 | ONC | Corrected unaudited interim results to 31 May 2022 | RNS |
12.07.2023 11:14 | ONC | Oncimmune names chief executive successor, while finance chief leaves | Alliance |
12.07.2023 07:00 | ONC | Appointment of new leadership team & board changes | RNS |
26.06.2023 11:10 | ONC | Change of registered office | RNS |
23.06.2023 12:08 | ONC | Oncimmune Holdings shakes up leadership and unveils new growth plan | Alliance |
23.06.2023 07:00 | ONC | Transition of Executive Leadership | RNS |
15.06.2023 17:16 | ONC | Correction to interim results | RNS |
13.06.2023 07:45 | ONC | Holding(s) in Company | RNS |
05.06.2023 16:02 | ONC | Director/PDMR Shareholding | RNS |
31.05.2023 13:31 | ONC | Oncimmune shares plummet as interim revenue falls by fifth | Alliance |
31.05.2023 07:00 | ONC | Interim Results | RNS |
22.05.2023 14:22 | ONC | Oncimmune sells two subsidiaries to Freenome for GBP13 million | Alliance |
22.05.2023 10:12 | ONC, NBB, LOGP | AIM WINNERS & LOSERS: Lansdowne and Barryroe slump after licence blow | Alliance |
22.05.2023 07:00 | ONC | Sale of Oncimmune Limited to Freenome | RNS |
03.04.2023 16:38 | ONC | Holding(s) in Company | RNS |
27.03.2023 11:07 | ONC | Result of GM | RNS |
20.03.2023 15:54 | ONC | UK shareholder meetings calendar - next 7 days | Alliance |
03.03.2023 07:00 | ONC | Posting of Annual Report and Notice of GM | RNS |
27.02.2023 14:36 | ONC | Result of AGM | RNS |
27.02.2023 14:27 | QTX, ONC, BKS | EARNINGS SUMMARY: Base Resources profit surges; Spectral MD optimistic | Alliance |
27.02.2023 10:37 | ONC, HERC, DCTA | AIM WINNERS & LOSERS: Elixirr meets guidance, in strong start to 2023 | Alliance |